The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB). La entrada Abdala vaccine candidate: 92.28% efficacy in its three doses se publicó primero en OnCubaNews English.

This is the highest figure published so far by the Cuban authorities, which each year disclose this data, by far exceeding the previous record of $5.57 billion in 2019. La entrada Cuban government: U.S. embargo causes losses of 9.157 billion between 2019 and 2020 se publicó primero en OnCubaNews English.

Mon, June 21, 2021, 8:05 PM·2 min read Marc Jranjk Original Article: Abdala Vaccine HAVANA, June 21 (Reuters) – Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.   The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% …

En Cuba se reporta un incremento notable de casos en poblaciones menores de 19 años, incluidos lactantes y recién nacidos. La entrada Centro Cristiano de Cárdenas apoya aislamiento pediátrico por covid se publicó primero en IPS Cuba.

La última publicación en vida del poeta y ensayista Roberto Fernández Retamar es una compilación de entrevistas publicada por Ediciones Unión. La entrada Roberto Fernández Retamar a su medida se publicó primero en IPS Cuba.

Minister Alejandro Gil Fernández explained that the conditions are currently being created for the design of legal norms, which still implies a conciliation process. La entrada Cuba: creation of micro, small and medium-sized enterprises announced for August-September se publicó primero en OnCubaNews English.

Cuba presenta el 23 de junio ante Naciones Unidas un nuevo informe sobre el bloqueo de EE.UU. Acérquese a los últimos acontecimientos en esta compendio de IPS Cuba. La entrada Bloqueo en la mira global se publicó primero en IPS Cuba.

Cuba’s Soberana 2 vaccine candidate shows 62 percent efficacy with two of its three doses in trials, says BioCubaFarma.

The director of the Finlay Vaccine Institute, Vicente Vérez, specified on state television that the percentage has been obtained from the intermediate study of the results in the volunteers to whom two doses of Soberana 02 were applied 28 days apart. La entrada Cuban Soberana 02 vaccine candidate shows 62% efficacy in clinical trials se …